Chemours
458 hedge funds and large institutions have $5.6B invested in Chemours in 2017 Q1 according to their latest regulatory filings, with 92 funds opening new positions, 109 increasing their positions, 157 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
458
Holders Change
+42
Holders Change %
+10.1%
% of All Funds
11.42%
Holding in Top 10
12
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+100%
% of All Funds
0.3%
New
92
Increased
109
Reduced
157
Closed
41
Calls
$111M
Puts
$44.3M
Net Calls
+$66.6M
Net Calls Change
+$40.9M
Top Buyers
| 1 |
BlackRock
New York
|
$738M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
$575M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
$113M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
$172M |
| 5 |
Renaissance Technologies
New York
|
$117M |
Top Sellers
| 1 |
GC
Greenlight Capital
New York
|
$193M |
| 2 |
SC
Sessa Capital
New York
|
$6.74M |
| 3 |
Norges Bank
Oslo,
Norway
|
$271M |
| 4 |
GC
GMT Capital
Atlanta,
Georgia
|
$2.69M |
| 5 |
Invesco
Atlanta,
Georgia
|
$36.9M |
